Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|September 13, 2021
Implementation and Access to Pre-exposure Prophylaxis for Human Immunodeficiency Virus by Men Who Have Sex With Men in EuropeBruno Sepodes, João Rocha, Jorge Batista, et al.
Clinical Pharmacology and Therapeutics|August 14, 2024
Comparative Analysis of Post-Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023Diana Mandslay, Diogo Almeida, Adriana Marques, et al.
British Journal of Pharmacology|June 6, 2006
Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shockOliver Murch, Marika Collin, Bruno Sepodes, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 22, 2002
The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the ratHelder Mota-Filipe, Bruno Sepodes, Michelle C McDonald, et al.
Shock (Augusta, Ga.)|June 5, 2010
Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac deathRui Maio, Bruno Sepodes, Nimesh S A Patel, et al.
Frontiers in Medicine|August 29, 2022
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020Maria Manuel Teixeira, Fábio Cardoso Borges, Paula Sousa Ferreira, et al.
Basic & Clinical Pharmacology & Toxicology|September 1, 2016
Anti-Inflammatory Effect of Erythropoietin in the TNBS-induced ColitisVanessa Mateus, João Rocha, Paula Alves, et al.
Drug Discovery Today|June 16, 2026
From complexity to approval in the European Union: regulatory pathways and data challenges in the evaluation of non-oncology orphan medicinesGaёlle Andriantafika, Heidi Janssen, Ewa Balkowiec-Iskra, et al.
Nature Reviews. Drug Discovery|March 16, 2013
Animal models for metabolic, neuromuscular and ophthalmological rare diseasesGuillaume Vaquer, Frida Rivière, Maria Mavris, et al.
Frontiers in Medicine|June 1, 2017
Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in EuropeAndreas M Farkas, Segundo Mariz, Violeta Stoyanova-Beninska, et al.
Pageof 8